Home・Список акций・Insulet Corp

Insulet Corp

Закрыт

СекторЗдравоохранение

141.07 1.31

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

135.72

Макс.

142.08

Ключевые показатели
By Trading Economics
Доход	-11M 91M
Продажи	-22M 762M
P/E Средняя по отрасли	39.65 68.51
Прибыль на акцию	1.42
Рентабельность продаж	11.96
Сотрудники	5,400
EBITDA	-23M 154M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+25.23% upside

Дивиденды
By Acuity
Следующий отчет о доходах	5 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-117M 12B
Предыдущая цена открытия	139.76
Предыдущая цена закрытия	141.07

Новостные настроения

By Acuity

16%

84%

30 / 340 Рейтинг в Healthcare

Insulet Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 авг. 2026 г., 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

6 авг. 2026 г., 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

5 авг. 2026 г., 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4 авг. 2026 г., 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3 авг. 2026 г., 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 июл. 2026 г., 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 июл. 2026 г., 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28 июл. 2026 г., 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27 июл. 2026 г., 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 июл. 2026 г., 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 июл. 2026 г., 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 июл. 2026 г., 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Сравнение c конкурентами

Изменение цены

Insulet Corp Прогноз

Целевая цена

By TipRanks

25.23% рост

Прогноз на 12 месяцев

Средняя 174.45 USD 25.23%

Максимум 216 USD

Минимум 144 USD

Основано на мнении 23 аналитиков Wall Street, спрогнозировавших целевые цены для Insulet Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

23 ratings

Покупка

Удержание

Продажа

Основано на мнении 23 аналитиков, присваивавших рейтинги акциям Insulet Corp – Данные за последние 3 месяца.

Настроения

By Acuity

30 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.